ScholarIQanswers from OpenAlex & ORCID
Bonnie Ky
ResearcherPublications, citations & collaboration network
Bonnie Ky is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bonnie Ky have?
ScholarIQindexed works
Bonnie Ky has 472 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bonnie Ky have?
ScholarIQcitation count
Bonnie Ky has 27,572 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bonnie Ky?
ScholarIQh-index
Bonnie Ky has an h-index of 73 in OpenAlex.
What is the i10-index of Bonnie Ky?
ScholarIQi10-index
Bonnie Ky has an i10-index of 191 in OpenAlex.
What is the ORCID of Bonnie Ky?
ScholarIQorcid
The ORCID for Bonnie Ky is on the source record.
What is the OpenAlex record for Bonnie Ky?
ScholarIQopenalex
The OpenAlex for Bonnie Ky is on the source record.
What are the most-cited papers on Bonnie Ky?
ScholarIQmost cited works
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, Riccardo Asteggiano, Marianne Aznar, Jutta Bergler‐Klein, Giuseppe Boriani, Daniela Cardinale, Raúl Córdoba, Bernard Cosyns, David J. Cutter, Evandro de Azambuja, Rudolf A. de Boer, Susan Dent, Dimitrios Farmakis, Sofie Gevaert, Diana A. Gorog, Joerg Herrmann, Daniel J. Lenihan, Javid J. Moslehi, Brenda Moura, Sonja S Salinger, Richard Stephens, Thomas Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G. Tocchetti, Peter van der Meer, Helena J. H. van der Pal, ESC Scientific Document Group, Patrizio Lancellotti, Franck Thuny, Magdy Abdelhamid, Victor Aboyans, Berthe M.P. Aleman, Joachim Alexandre, Ana Barac, Michael A Borger, Rubén Casado-Arroyo, Jennifer Cautela, Jolanta Čelutkienė, Maja Čikeš, Alain Cohen‐Solal, Kreena Dhiman, Stéphane Éderhy, Thor Edvardsen, Laurent Fauchier, Michael G. Fradley, Julia Grapsa, Sigrun Halvorsen, Michael Heuser, Marc Humbert, Tiny Jaarsma, Thomas Kahan, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Bonnie Ky, Ulf Landmesser, Basil S Lewis, Aleš Linhart, Gregory Y H Lip, Maja‐Lisa Løchen, Katarzyna Małaczyńska-Rajpold, Marco Metra, Richard Mindham, Marie Moonen, Tomas G. Neilan, Jens Cosedis Nielsen, Anna-Sonia Petronio, Eva Prescott, Amina Rakisheva, Joe‐Elie Salem, Gianluigi Savarese, Marta Sitges, Jurriën M. ten Berg, Rhian M. Touyz, Agnieszka Tycińska, Matthias Wilhelm, José Luis Zamorano, Nadia Laredj, Parounak Zelveian, Peter P. Rainer, Fuad Samadov, Uladzimir Andrushchuk, Bernhard Gerber, Mirsad Selimović, Elena Kinova, Jure Samardžić, Evagoras Economides, Radek Pudil, Kirsten M Nielsen, Tarek A Kafafy, Riina Vettus, Suvi Tuohinen, Stéphane Éderhy, Zurab Pagava, Tienush Rassaf, Αlexandros Briasoulis
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, Sarju Ganatra, Ana Barac, Anne Blaes, J. Herrmann, Charles Porter, Alexander R. Lyon, P Lancellotti, Aarti Patel, Jeanne M. DeCara, Joshua D. Mitchell, Eric Harrison, Javid J. Moslehi, Ronald Witteles, Maria Grazia Calabró, Roberto Orecchia, Evandro de Azambuja, J. L. Zamorano, Ronald J. Krone, Zaza Iakobishvili, Joseph R. Carver, Saro H. Armenian, Bonnie Ky, Daniela Cardinale, Carlo M. Cipolla, Susan Dent, Karin Jordan
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana, James L. Januzzi, Bonnie Ky, Timothy C. Tan, Victor Cohen, José Banchs, Joseph R. Carver, Susan E. Wiegers, Randolph P. Martin, Michael H. Picard, Robert E. Gerszten, Elkan F. Halpern, Jonathan Passeri, Irene Kuter, Marielle Scherrer‐Crosbie
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yu. N. Belenkov, Stuart D. Rosen, Zaza Iakobishvili, Aaron L. Sverdlov, Ludhmila Abrahão Hajjar, Ariane Vieira Scarlatelli Macedo, Charlotte Manisty, Fortunato Ciardiello, Dimitrios Farmakis, Rudolf A. de Boer, Hadi Skouri, Thomas Suter, Daniela Cardinale, Ronald Witteles, Michael G. Fradley, Joerg Herrmann, Robert F. Cornell, Ashutosh Wechelaker, Michael J. Mauro, Dragana Milojković, Hugues de Lavallade, Frank Ruschitzka, Andrew J.S. Coats, Petar Seferović, Ovidiu Chioncel, Thomas Thum, Johann Bauersachs, María Sol Andrés, David J. Wright, Teresa López‐Fernández, Chris Plummer, Daniel J. Lenihan
Sex differences in heart failure
Carolyn S.P. Lam, Clare Arnott, A. Beale, Chanchal Chandramouli, Denise Hilfiker‐Kleiner, David M. Kaye, Bonnie Ky, Bernadet T. Santema, Karen Sliwa, Adriaan A. Voors